Pfam Domains GO Terms
| mitotic nuclear envelope reassembly |
| peptidyl-serine dephosphorylation |
| nuclear envelope reassembly |
| protein phosphatase type 2A complex |
| protein phosphatase 2A binding |
| protein phosphatase regulator activity |
| response to morphine |
| response to isoquinoline alkaloid |
| tau protein binding |
| nuclear envelope organization |
| protein serine/threonine phosphatase activity |
| response to anesthetic |
| response to alkaloid |
| regulation of phosphoprotein phosphatase activity |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| G2/M transition of mitotic cell cycle |
| nucleus organization |
| cell cycle G2/M phase transition |
| regulation of protein dephosphorylation |
| regulation of phosphatase activity |
| response to ammonium ion |
| nuclear-transcribed mRNA catabolic process |
| regulation of dephosphorylation |
| protein dephosphorylation |
| mRNA catabolic process |
| RNA catabolic process |
| protein-containing complex binding |
| mitotic cell cycle phase transition |
| cell cycle phase transition |
| response to xenobiotic stimulus |
| dephosphorylation |
| glutamatergic synapse |
| nucleobase-containing compound catabolic process |
| endomembrane system organization |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| aromatic compound catabolic process |
| organic cyclic compound catabolic process |
| mitotic cell cycle process |
| mitotic cell cycle |
| mRNA metabolic process |
| membrane organization |
| cellular macromolecule catabolic process |
| response to organic cyclic compound |
| cell cycle process |
| response to organonitrogen compound |
| response to drug |
| macromolecule catabolic process |
| response to nitrogen compound |
| regulation of hydrolase activity |
| cell cycle |
| RNA metabolic process |
| negative regulation of gene expression |
| organic substance catabolic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| cellular catabolic process |
| regulation of protein modification process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 1/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 1/33 |
| central nervous system | 1/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 1/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 1/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 4/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 2/22 |
| urinary tract | 2/29 |
| uterus | 0/5 |
Expression Distribution